EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

D[His26]NPY, an agonist of NPY receptor 1, averts traumatic stress-induced behavioral deficits in male and female rats

Arax Tanelian, Bistra Nankova, Moshe Weiss, Esther L Sabban

Psychopharmacology · 19.03.2026

DOI: 10.1007/s00213-026-07044-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychopharmacology, online erschienen am 19.03.2026. Verfasst von Arax Tanelian und 3 weiteren Autor:innen. Beteiligte Einrichtung: New York Medical College, Valhalla, NY, 10595, USA. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New York Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropeptide Y (NPY) has emerged as a key modulator of stress resilience, primarily through activation of the Y1 receptor (Y1R). We previously demonstrated that intranasal delivery of the Y1R-selective analog D[His 26 ]NPY at the time of trauma induced by Single Prolonged Stress (SPS), a validated rodent model for post-traumatic stress disorder (PTSD), effectively prevented stress-induced behavioral impairments in male rats. D[His 26 ]NPY was more effective than either intranasal administration of native NPY or the Y1R agonist [Leu 31 Pro 34 ]NPY. In females, who are more susceptible to stress-related anxiety disorders and PTSD, native NPY has shown limited efficacy. Here, we investigated: (1) efficacy of intranasal D[His 26 ]NPY in female rats; (2) time-dependence of intranasal administration of D[His 26 ]NPY effectiveness for males, in preventing or reversing behavioral impairments. Our results revealed that in female rats, D[His 26 ]NPY produced robust anxiolytic effects at lower doses than native NPY. In male rats, intranasal D[His 26 ]NPY administered at the time of trauma, or 1 day before, averted the development of SPS-induced anxiety and social interaction deficits. Even when given two days prior to the traumatic stress intranasal D[His 26 ]NPY was partiallly effective. However, in contrast to native NPY, D[His 26 ]NPY failed to reverse the established behavioral impairments, when administered two weeks after SPS. These findings suggest that despite sex-specific differences, nose to brain delivery of the Y1R agonist D[His 26 ]NPY could be especially useful as a prophylactic treatment to prevent long-term adverse harmful effects of traumatic stress in both males and females.

Schlagwörter

Stichwörter der Autor:innen

AnxietyIntranasalNPY receptor 1Neuropeptide YNose to brainPTSD modelProphylaxisSex differencesSingle prolonged stressSocial interaction

Autor:innen und Institutionen

  • New York Medical College, Valhalla, NY, 10595, USA.
  • New York Medical College, Valhalla, NY, 10595, USA. Esther_Sabban@nymc.edu.

Förderung

  • New York Medical College

Zitieren

APA

Tanelian, A., Nankova, B., Weiss, M., & Sabban, E. L. (2026). D[His26]NPY, an agonist of NPY receptor 1, averts traumatic stress-induced behavioral deficits in male and female rats. Psychopharmacology. https://doi.org/10.1007/s00213-026-07044-5

Vancouver

Tanelian A, Nankova B, Weiss M, Sabban EL. D[His26]NPY, an agonist of NPY receptor 1, averts traumatic stress-induced behavioral deficits in male and female rats. Psychopharmacology. 2026. doi:10.1007/s00213-026-07044-5

BibTeX
@article{Tanelian2026,
  author = {Tanelian, Arax and Nankova, Bistra and Weiss, Moshe and Sabban, Esther L},
  title = {D[His26]NPY, an agonist of NPY receptor 1, averts traumatic stress-induced behavioral deficits in male and female rats},
  journal = {Psychopharmacology},
  year = {2026},
  doi = {10.1007/s00213-026-07044-5}
}
Kostenlos starten →